Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agathe Landoas

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Annales Pharmaceutiques Francaises|October 1, 2024
[Risk analysis applied to the monitoring of immunosuppressor concentrations in lung transplant recipients]Agathe Landoas, Romane Chapuis, Amandine Briault, et al.
Revue De L'Infirmiere|January 19, 2024
Agathe Landoas, Armance Grévy, Claire Trochet, et al.
International Immunopharmacology|October 19, 2024
The Favorable impact of everolimus on Chronic lung allograft dysfunction in lung transplant recipientsAgathe Landoas, Quentin Perrier, Loïc Falque, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Annales Pharmaceutiques Francaises|October 1, 2024
[Risk analysis applied to the monitoring of immunosuppressor concentrations in lung transplant recipients]Agathe Landoas, Romane Chapuis, Amandine Briault, et al.
Revue De L'Infirmiere|January 19, 2024
Agathe Landoas, Armance Grévy, Claire Trochet, et al.
International Immunopharmacology|October 19, 2024
The Favorable impact of everolimus on Chronic lung allograft dysfunction in lung transplant recipientsAgathe Landoas, Quentin Perrier, Loïc Falque, et al.
Pageof 1